David Reardon

46PUBLICATIONS
451CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyGene expression (incl. microarray and other genome-wide approaches)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Aug 05, 2026
Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.

|Jul 29, 2026
Glioblastoma: Overcoming fundamental biological and delivery barriers to therapy.

|Jul 22, 2026
Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cells.

|Jul 15, 2026
Erdafitinib in Patients With Advanced Solid Tumors With FGFR Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts.

|Jun 03, 2026
Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma.

|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Pageof 8

Frequent Collaborators

16 joint publications

Patrick Y Wen

13 joint publications

E Antonio Chiocca

13 joint publications

Keith Ligon

8 joint publications

Raymond Y Huang